These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 22068664

  • 1. IBS patients show frequent fluctuations between loose/watery and hard/lumpy stools: implications for treatment.
    Palsson OS, Baggish JS, Turner MJ, Whitehead WE.
    Am J Gastroenterol; 2012 Feb; 107(2):286-95. PubMed ID: 22068664
    [Abstract] [Full Text] [Related]

  • 2. Episodic nature of symptoms in irritable bowel syndrome.
    Palsson OS, Baggish J, Whitehead WE.
    Am J Gastroenterol; 2014 Sep; 109(9):1450-60. PubMed ID: 24980882
    [Abstract] [Full Text] [Related]

  • 3. Characterization of symptoms in irritable bowel syndrome with mixed bowel habit pattern.
    Su AM, Shih W, Presson AP, Chang L.
    Neurogastroenterol Motil; 2014 Jan; 26(1):36-45. PubMed ID: 23991913
    [Abstract] [Full Text] [Related]

  • 4. Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research.
    Fehnel SE, Ervin CM, Carson RT, Rigoni G, Lackner JM, Coons SJ, Critical Path Institute Patient-Reported Outcome Consortium’s Irritable Bowel Syndrome Working Group.
    Value Health; 2017 Apr; 20(4):618-626. PubMed ID: 28408004
    [Abstract] [Full Text] [Related]

  • 5. A Novel Method to Classify and Subgroup Patients With IBS Based on Gastrointestinal Symptoms and Psychological Profiles.
    Black CJ, Yiannakou Y, Guthrie EA, West R, Houghton LA, Ford AC.
    Am J Gastroenterol; 2021 Feb 01; 116(2):372-381. PubMed ID: 33110014
    [Abstract] [Full Text] [Related]

  • 6. Further characterization of painful constipation (PC): clinical features over one year and comparison with IBS.
    Drossman DA, Morris C, Hu Y, Leserman J, Dalton C, Toner B, Diamante N, Bangdiwala S.
    J Clin Gastroenterol; 2008 Feb 01; 42(10):1080-8. PubMed ID: 18949838
    [Abstract] [Full Text] [Related]

  • 7. Importance of diarrhea in evaluating constipation in irritable bowel syndrome clinical studies.
    Basseri RJ, Kunkel D, Low K, Conklin JL, Pimentel M.
    J Clin Gastroenterol; 2011 Oct 01; 45(9):790-3. PubMed ID: 21301356
    [Abstract] [Full Text] [Related]

  • 8. Inaccuracy of patient-reported descriptions of and satisfaction with bowel actions in irritable bowel syndrome.
    Halmos EP, Biesiekierski JR, Newnham ED, Burgell RE, Muir JG, Gibson PR.
    Neurogastroenterol Motil; 2018 Feb 01; 30(2):. PubMed ID: 28799291
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of a Chinese Herbal Medicine in Providing Adequate Relief of Constipation-predominant Irritable Bowel Syndrome: A Randomized Controlled Trial.
    Bensoussan A, Kellow JE, Bourchier SJ, Fahey P, Shim L, Malcolm A, Boyce P.
    Clin Gastroenterol Hepatol; 2015 Nov 01; 13(11):1946-54.e1. PubMed ID: 26133902
    [Abstract] [Full Text] [Related]

  • 10. Clinical patterns over time in irritable bowel syndrome: symptom instability and severity variability.
    Mearin F, Baró E, Roset M, Badía X, Zárate N, Pérez I.
    Am J Gastroenterol; 2004 Jan 01; 99(1):113-21. PubMed ID: 14687152
    [Abstract] [Full Text] [Related]

  • 11. The Impact of Stool Consistency on Bowel Movement Satisfaction in Patients With IBS-C or CIC Treated With Linaclotide or Other Medications: Real-World Evidence From the CONTOR Study.
    Taylor DCA, Abel JL, Doshi JA, Martin C, Goolsby Hunter A, Essoi B, Korrer S, Reasner DS, Carson RT, Chey WD.
    J Clin Gastroenterol; 2019 Jan 01; 53(10):737-743. PubMed ID: 31361710
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): study protocol for a randomised controlled trial.
    Leighton MP, Lam C, Mehta S, Spiller RC.
    Trials; 2013 Jan 09; 14():10. PubMed ID: 23302220
    [Abstract] [Full Text] [Related]

  • 13. Cognitive and Behavioral Differences Between Subtypes in Refractory Irritable Bowel Syndrome.
    Windgassen S, Moss-Morris R, Everitt H, Sibelli A, Goldsmith K, Chalder T.
    Behav Ther; 2019 May 09; 50(3):594-607. PubMed ID: 31030876
    [Abstract] [Full Text] [Related]

  • 14. Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit.
    Houghton LA, Lea R, Agrawal A, Reilly B, Whorwell PJ.
    Gastroenterology; 2006 Oct 09; 131(4):1003-10. PubMed ID: 17030170
    [Abstract] [Full Text] [Related]

  • 15. Symptom Stability in Rome IV vs Rome III Irritable Bowel Syndrome.
    Barberio B, Houghton LA, Yiannakou Y, Savarino EV, Black CJ, Ford AC.
    Am J Gastroenterol; 2021 Feb 01; 116(2):362-371. PubMed ID: 33009062
    [Abstract] [Full Text] [Related]

  • 16. Multicenter observational study on functional bowel disorders diagnosed using Rome III diagnostic criteria in Japan.
    Ono M, Kato M, Miyamoto S, Tsuda M, Mizushima T, Ono S, Nakagawa M, Mabe K, Nakagawa S, Muto S, Shimizu Y, Kudo M, Katsuki S, Meguro T, Sakamoto N.
    J Gastroenterol; 2018 Aug 01; 53(8):916-923. PubMed ID: 29305648
    [Abstract] [Full Text] [Related]

  • 17. Double-Blind Placebo-Controlled Study of Rifaximin and Lactulose Hydrogen Breath Test in Gulf War Veterans with Irritable Bowel Syndrome.
    Tuteja AK, Talley NJ, Stoddard GJ, Verne GN.
    Dig Dis Sci; 2019 Mar 01; 64(3):838-845. PubMed ID: 30370492
    [Abstract] [Full Text] [Related]

  • 18. Subtypes of irritable bowel syndrome based on abdominal pain/discomfort severity and bowel pattern.
    Heitkemper M, Cain KC, Shulman R, Burr R, Poppe A, Jarrett M.
    Dig Dis Sci; 2011 Jul 01; 56(7):2050-8. PubMed ID: 21290181
    [Abstract] [Full Text] [Related]

  • 19. Pain is temporally related to eating but not to defaecation in the irritable bowel syndrome (IBS). Patients' description of diarrhea, constipation and symptom variation during a prospective 6-week study.
    Ragnarsson G, Bodemar G.
    Eur J Gastroenterol Hepatol; 1998 May 01; 10(5):415-21. PubMed ID: 9619389
    [Abstract] [Full Text] [Related]

  • 20. The effect of inactivated Lactobacillus LB fermented culture medium on symptom severity: observational investigation in 297 patients with diarrhea-predominant irritable bowel syndrome.
    Tarrerias AL, Costil V, Vicari F, Létard JC, Adenis-Lamarre P, Aisène A, Batistelli D, Bonnaud G, Carpentier S, Dalbiès P, Ecuer S, Etienne J, Fantoli M, Grunberg B, Lannoy P, Lapuelle J, Margulies A, Neumeier M, Rouillon JM, Schmets L, Pingannaud MP, Coulom P, Kholer F, Canard JM.
    Dig Dis; 2011 May 01; 29(6):588-91. PubMed ID: 22179215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.